Internal Medicine, Rheumatology · Sarasota, FL
NPI
1770845711
Since 2012
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
8383 S Tamiami Trl Unit 115
Sarasota, FL, 34238
Phone (941) 497-4069
Groups this clinician bills Medicare through
Medicare paid, 2024
$944K
94,168 services
Medicare patients, 2024
593
Average age 74
Drug cost, 2024
$7.0M
11,478 prescriptions
Company payments, 2025
$2,825
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sampath K Manickam was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 47,200 times for 12 patients. In total Sampath K Manickam billed 94,168 services in 43 codes, and Medicare paid $944K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 47,200 | 12 | $3.61 | $171K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 14,350 | 15 | $9.10 | $131K |
| J0897 Injection, denosumab, 1 mg | Office | 6,840 | 68 | $20.42 | $140K |
| 99214 Office E&M - Established | Office | 300 | 231 | $86.12 | $26K |
| 96372 Injection Administration | Office | 299 | 92 | $10.28 | $3,073 |
| 99213 Office E&M - Established | Office | 244 | 225 | $60.98 | $15K |
| 96365 Intravenous Infusion, Hydration | Office | 180 | 39 | $43.74 | $7,873 |
| 36415 Venipuncture Blood Collection | Office | 123 | 103 | $8.65 | $1,064 |
| 99215 Office E&M - Established | Office | 120 | 109 | $130.19 | $16K |
| 80053 Clinical Chemistry | Office | 119 | 95 | $10.35 | $1,232 |
| 85025 Blood Count | Office | 111 | 89 | $7.61 | $845 |
| 96413 Chemotherapy Administration | Office | 77 | 16 | $87.84 | $6,764 |
| 99205 Office E&M - New | Office | 36 | 36 | $143.61 | $5,170 |
| 86140 Clinical Chemistry | Office | 31 | 25 | $5.08 | $157 |
| 99204 Office E&M - New | Office | 31 | 31 | $101.03 | $3,132 |
By year: 2022 $1.2M for 107,902 services; 2023 $892K for 86,787 services; 2024 $944K for 94,168 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 123 | 103 | $8.65 | $1,064 |
| 80053 Clinical Chemistry | 119 | 95 | $10.35 | $1,232 |
| 85025 Blood Count | 111 | 89 | $7.61 | $845 |
| 86140 Clinical Chemistry | 31 | 25 | $5.08 | $157 |
| 85652 Clinical Chemistry | 29 | 25 | $2.65 | $76.85 |
| 84550 Clinical Chemistry | 12 | 12 | $4.43 | $53.16 |
Medicare prescription drug claims, 2024
In 2024, the drug Sampath K Manickam prescribed most often to Medicare patients was Prednisone, with 1,240 prescriptions and refills. In total Sampath K Manickam wrote 11,478 Medicare prescriptions that cost $7.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,240 | 2,385 | 342 | $8,616 |
| Hydroxychloroquine Sulfate Generic | 875 | 1,972 | 271 | $33K |
| Leflunomide Generic | 708 | 1,650 | 239 | $40K |
| Methotrexate Methotrexate Sodium | 660 | 1,533 | 200 | $16K |
| Tramadol Hcl Generic | 644 | 657 | 170 | $7,786 |
| Celecoxib Generic | 516 | 951 | 186 | $18K |
| Meloxicam Generic | 508 | 1,059 | 173 | $2,100 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 454 | 454 | 97 | $11K |
| Gabapentin Generic | 378 | 756 | 108 | $6,611 |
| Sulfasalazine Generic | 373 | 738 | 107 | $8,247 |
| Methylprednisolone Generic | 297 | 319 | 167 | $2,129 |
| Diclofenac Sodium Generic | 283 | 503 | 86 | $4,864 |
| Duloxetine Hcl Generic | 243 | 562 | 79 | $6,951 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 238 | 238 | 44 | $9,036 |
| Pregabalin Generic | 209 | 253 | 43 | $5,176 |
Brand drugs: 1,341 claims; generic drugs: 10,123 claims; opioid claims: 1,642.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sampath K Manickam $2,825 ($2,825 in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbvie Inc. with $428.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 22 | $428 |
| GlaxoSmithKline, LLC. GSK | 14 | $352 |
| Janssen Biotech, Inc. JNJ | 11 | $347 |
| Amgen Inc. AMGN | 18 | $345 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $303 |
| UCB, Inc. UCB.BR | 9 | $232 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $178 |
| Pfizer Inc. PFE | 11 | $148 |
| Mallinckrodt Hospital Products Inc. | 3 | $90.5 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $77.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.